The effectiveness of substance use interventions for homeless and vulnerably housed persons: A systematic review of systematic reviews on supervised consumption facilities, managed alcohol programs, and pharmacological agents for opioid use disorder
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Substance use is disproportionately high among people who are homeless or vulnerably housed. We performed a systematic overview of reviews examining the effects of selected harm reduction and pharmacological interventions on the health and social well-being of people who use substances, with a focus on homeless populations. METHODS AND FINDINGS: We searched MEDLINE, EMBASE, PsycINFO, Joanna Briggs Institute EBP, Cochrane Database of Systematic Reviews and DARE for systematic reviews from inception to August 2019. We conducted a grey literature search and hand searched reference lists. We selected reviews that synthesized evidence on supervised consumption facilities, managed alcohol programs and pharmacological interventions for opioid use disorders. We abstracted data specific to homeless or vulnerably housed populations. We assessed certainty of the evidence using the GRADE approach. Our search identified 483 citations and 30 systematic reviews met all inclusion criteria, capturing the results from 442 primary studies. This included three reviews on supervised consumption facilities, 24 on pharmacological interventions, and three on managed alcohol programs. Supervised consumption facilities decreased lethal overdoses and other high risk behaviours without any significant harm, and improved access to care. Pharmaceutical interventions reduced mortality, morbidity, and substance use, but the impact on retention in treatment, mental illness and access to care was variable. Managed alcohol programs reduced or stabilized alcohol consumption. Few studies on managed alcohol programs reported deaths. CONCLUSIONS: Substance use is a common chronic condition impacting homeless populations. Supervised consumption facilities reduce overdose and improve access to care, while pharmacological interventions may play a role in reducing harms and addressing other morbidity. High quality evidence on managed alcohol programs is limited.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rayyan-a web and mobile app for systematic reviews.
Ouzzani, M., Hammady, H., Fedorowicz, Z., & Elmagarmid, A. (2016) · Systematic Reviews · doi:10.1186/s13643-016-0384-4 · Cited by 26,092
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305 · cited 2×
“We assessed the certainty of the available numerical evidence for critical patient-important outcomes (mortality, morbidity, substance use) using GRADE methodology, considering risk of bias of the primary studies, indirectness, imprecision and inconsistency [26] (See Table 2: GRADE definitions).”
Cochrane Handbook for Systematic Reviews of Interventions
(2019) · doi:10.1002/9781119536604 · Cited by 14,828
Shea, B. J., Reeves, B. C., Wells, G., Thuku, M., Hamel, C., Moran, J., Moher, D., Tugwell, P., Welch, V., Kristjansson, E., et al. (2017) · BMJ · doi:10.1136/bmj.j4008 · Cited by 10,636
Self-citationPopay, J., Roberts, H., Sowden, A., Petticrew, M., Arai, L., Rodgers, M., Britten, N., Roen, K., & Duffy, S. (2006) · Lancaster University · doi:10.13140/2.1.1018.4643 · Cited by 2,070
Sordo, L., Barrio, G., Bravo, M. J., Indave, B. I., Degenhardt, L., Wiessing, L., Ferri, M., & Pastor-Barriuso, R. (2017) · BMJ · doi:10.1136/bmj.j1550 · Cited by 1,816 · cited 4×
“Results suggest that buprenorphine and methadone are the most effective pharmaceutical agents to address mortality and morbidity among people who use substances [50,57,60].”
Influentialvan Boekel, L. C., Brouwers, E. P. M., van Weeghel, J., & Garretsen, H. F. L. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.02.018 · Cited by 1,810
Fazel, S., Geddes, J. R., & Kushel, M. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61132-6 · Cited by 1,568
Risk environments and drug harms: a social science for harm reduction approach
Rhodes, T. (2009) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2008.10.003 · Cited by 948
Aldridge, R. W., Story, A., Hwang, S. W., Nordentoft, M., Luchenski, S. A., Hartwell, G., Tweed, E. J., Lewer, D., Vittal Katikireddi, S., & Hayward, A. C. (2018) · The Lancet · doi:10.1016/s0140-6736(17)31869-x · Cited by 905 · cited 1×
“Harm reduction approaches are particularly relevant for homeless populations given the extreme health inequities and stigma impacting both substance use and homelessness [1,22,23].”
Mortality Among Homeless Adults in Boston: Shifts in Causes of Death Over a 15-Year Period
Baggett, T. P., Hwang, S. W., O’Connell, J. J., Porneala, B. C., Stringfellow, E. J., Orav, E. J., Singer, D. E., & Rigotti, N. A. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.1604 · Cited by 566 · cited 1×
“There is yet to be a systematic review considering their use among homeless and vulnerably housed populations, despite their disproportionate representation in the overdose epidemic [95,96].”
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Mattick, R. P., Kimber, J., Breen, C., & Davoli, M. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002207.pub3 · Cited by 501
Khoury, L., Tang, Y. L., Bradley, B., Cubells, J. F., & Ressler, K. J. (2010) · Depression and Anxiety · doi:10.1002/da.20751 · Cited by 488 · cited 1×
“Childhood traumatic experiences, posttraumatic stress disorder and adult exposure to other traumatic experiences can also influence substance use [8].”
The GRADE Evidence to Decision (EtD) framework for health system and public health decisions
for the GRADE Working Group, Moberg, J., Oxman, A. D., Rosenbaum, S., Schünemann, H. J., Guyatt, G., Flottorp, S., Glenton, C., Lewin, S., Morelli, A., et al. (2018) · Health Research Policy and Systems · doi:10.1186/s12961-018-0320-2 · Cited by 376
Reducing the harm of opioid overdose with the safe use of naloxone: a pharmacologic review
Kim, H. K., & Nelson, L. S. (2015) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2015.1037274 · Cited by 116 · cited 1×
“Recent literature continues to highlight the importance of naloxone in averting overdose-related deaths [91,92].”
Canavan, R., Barry, M. M., Matanov, A., Barros, H., Gabor, E., Greacen, T., Holcnerová, P., Kluge, U., Nicaise, P., Moskalewicz, J., et al. (2012) · BMC Health Services Research · doi:10.1186/1472-6963-12-222 · Cited by 116
Housing and harm reduction: what is the role of harm reduction in addressing homelessness?
Pauly, B. (., Reist, D., Belle-Isle, L., & Schactman, C. (2013) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2013.03.008 · Cited by 113 · cited 1×
“Harm reduction approaches are particularly relevant for homeless populations given the extreme health inequities and stigma impacting both substance use and homelessness [1,22,23].”
Milloy, M.-J., Kerr, T., Bangsberg, D. R., Buxton, J., Parashar, S., Guillemi, S., Montaner, J., & Wood, E. (2012) · AIDS Patient Care and STDs · doi:10.1089/apc.2011.0169 · Cited by 112
Wilder, C., Lewis, D., & Winhusen, T. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.02.012 · Cited by 109
A systematic review on the efficacy of naltrexone maintenance treatment in opioid dependence
Kirchmayer, U., Davoli, M., Verster, A. D., Amato, L., Ferri, A., & Perucci, C. A. (2002) · Addiction · doi:10.1046/j.1360-0443.2002.00217.x · Cited by 106
Boucher, L. M., Marshall, Z., Martin, A., Larose-Hébert, K., Flynn, J. V., Lalonde, C., Pineau, D., Bigelow, J., Rose, T., Chase, R., et al. (2017) · Harm Reduction Journal · doi:10.1186/s12954-017-0145-2 · Cited by 90
Self-citationHenwood, B. F., Padgett, D. K., & Tiderington, E. (2014) · The Journal of Behavioral Health Services & Research · doi:10.1007/s11414-013-9318-2 · Cited by 46 · cited 1×
“Despite the substantial unmet care needs of this population, people struggling with both substance use and homelessness experience overlapping barriers to accessing care, including stigma related to care itself [9], and abstinence-based treatment first housing services [10,11].”
Cited by
Dow-Fleisner, S. J., Lomness, A., & Woolgar, L. (2022) · Emerging Trends in Drugs, Addictions, and Health · doi:10.1016/j.etdah.2022.100046 · Cited by 31
O'Leary, C., Ralphs, R., Stevenson, J., Smith, A., Harrison, J., Kiss, Z., & Armitage, H. (2024) · Campbell Systematic Reviews: Better Evidence for a Better World · doi:10.1002/cl2.1396 · Cited by 15
Nurse-led intervention to decrease drug use among LTBI positive homeless adults
Nyamathi, A., Morisky, D., Wall, S. A., Yadav, K., Shin, S., Hall, E., Chang, A. H., White, K., Arce, N., Parsa, T., et al. (2022) · Public Health Nursing · doi:10.1111/phn.13044 · Cited by 5
Metadata
- Authors
- Magwood, O., Salvalaggio, G., Beder, M., Kendall, C., Kpade, V., Daghmach, W., Habonimana, G., Marshall, Z., Snyder, E., O’Shea, T., Lennox, R., Hsu, H., Tugwell, P., & Pottie, K.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2020-01-16
- Volume
- 15
- Issue
- 1
- Pages
- e0227298
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2999459583
- Cited by
- 118
- References
- 22
- FWCI
- 4.01
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.